It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 1993.
1993 | Chandigarh, Chandigarh, India | ActiveUltra Chiron Pharmaceuticals Pvt Ltd, a active private limited company, was established on 20 July 1993 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231CH1993PTC013535. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.97 M.
It upholds a compliant status. Its leadership includes Mitesh Kumar (Director), Sadhu Singh (Director), Rajesh Biswanath Shrivastava (Director). Past directors included Mitesh Kumar, . Sudhakar, Deepak Mittal. It holds ₹1.10 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 80 Industrial Area Phase Ii, Chandigarh, Chandigarh, 160001.
U24231CH1993PTC013535
013535
20 July 1993
₹3.00 M
₹2.97 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Ultra Chiron Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mitesh Kumar | Director | 24 Feb 2016 | Current |
| Sadhu Singh | Director | 12 Mar 1999 | Current |
| Rajesh Biswanath Shrivastava | Director | 16 Aug 2019 | Current |
| Sanjeev Kumar | Managing Director | 20 Jul 1993 | Current |
| Amrik Singh | Whole-Time Director | 23 Dec 2014 | Current |
| Ashok Kumar Mishra | Additional Director | 06 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Whole-Time Director | 16 Oct 2018 | Past |
| Pramod Abcsdd | Director | 09 Nov 2015 | Past |
| Pramod Abcsdd | Director | 17 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ultra Chiron Pharmaceuticals Pvt Ltd, for the financial year ended 2024, experienced significant growth in revenue, with a 30.14% increase. The company also saw a substantial fall in profitability, with a 55.15% decrease in profit. The company's net worth moved up by a moderate rise of 4.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Ultra Chiron Pharmaceuticals had a public holding of 1.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,100,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 1997 | Indian Overseas Bank | ₹0.55 M | Open |
| 10 May 1997 | Indian Overseas Bank | ₹0.55 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ultra Chiron Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ultra Chiron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ultra Chiron Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ashok Kumar Mishra was appointed as a Additional Director was appointed as a Additional Director on 06 Mar 2025 & has been associated with this company since 8 months 27 days . was documented.
Ultra Chiron Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Ultra Chiron Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
The activity Rajesh Biswanath Shrivastava was appointed as a Director was appointed as a Director on 16 Aug 2019 & has been associated with this company since 6 years 3 months . was completed.
Mitesh Kumar was appointed as a Director was appointed as a Director on 24 Feb 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.
The activity Amrik Singh was appointed as a Whole-time director was appointed as a Whole-time director on 23 Dec 2014 & has been associated with this company since 10 years 11 months . was completed.
The CIN of Ultra Chiron Pharmaceuticals Pvt Ltd is U24231CH1993PTC013535.
Ultra Chiron Pharmaceuticals Pvt Ltd is headquartered at Plot No 80 Industrial Area Phase Ii, Chandigarh, Chandigarh, 160001.
Ultra Chiron Pharmaceuticals Pvt Ltd was incorporated on 20 July 1993.
The current directors of Ultra Chiron Pharmaceuticals Pvt Ltd are
The primary industry of Ultra Chiron Pharmaceuticals Pvt Ltd is Manufacturing.
Ultra Chiron Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Ultra Chiron Pharmaceuticals Pvt Ltd is ₹3.00 M, and the paid-up capital is ₹2.97 M.
The compliance status of Ultra Chiron Pharmaceuticals Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX